Stories & News

LRA Urges Congress to Ensure Lupus Patients Maintain Access to Hydroxychloroquine

April 3, 2020 The President and CEO of the LRA, Kenneth Farber wrote personally to Speaker Nancy Pelosi and Leader...

Lupus Research News

Iguratimod as an Alternative Therapy for Resistant Lupus Nephritis

April 1, 2020 An investigational treatment, iguratimod showed positive results in an early clinical study of people with lupus nephritis...

New Awardees Announced by the Lupus Research Program that Advocates Helped Create

April 1, 2020 Thirteen new applications for promising scientific studies were just recommended for funding through the Lupus Research Program...

Lupus Research News

The U.S. Department of Health and Human Services Accepts Donations of Hydroxychloroquine as Possible Treatments for COVID-19 Patients

March 31, 2020 A statement issued March 29 by the U.S. Department of Health and Human Services (HHS) announced that...

Lupus Research News

Actions from Pharmaceutical Companies to Preserve Hydroxychloroquine (Plaquenil) Supply

March 30, 2020 The rheumatology community has been in discussions with the U.S. Food and Drug Administration and many pharmaceutical...

DECLARACIÓN DEL 26 DE MARZO: La Alianza para la investigación de Lupus pone en perspectiva la escasez de Plaquenil (hidroxicloroquina) para la comunidad con lupus

26 de marzo de 2020 La Alianza para la investigación de Lupus (LRA), la principal organización de investigación del mundo...

Lupus Research News

CVS Preserving Plaquenil Supply for Patients Taking It

March 26, 2020 CVS put out the following statement yesterday assuring its clients that the company is protecting a supply...

LRA Sponsors COVID-19 Global Rheumatology Alliance

March 25, 2020 LRA Sponsors COVID-19 Global Rheumatology Alliance The LRA is proud to be among the sponsors of the COVID-19...

Hidroxicloroquina: fármaco típico para tratar el Lupus a prueba para el COVID-19

19 de marzo de 2020 En diciembre de 2019, se identificó un nuevo virus llamado SARS-COV-2 en Wuhan, China. Se...

Hydroxychloroquine: Common Lupus Drug in Testing for COVID-19

March 19, 2020 In December 2019, a new virus called SARS-COV-2 was identified in Wuhan, China. This virus was found...

Actualización sobre COVID-19: un mensaje del presidente y director ejecutivo de la LRA

18 de marzo de 2020 Estimados amigos: Su bienestar es la máxima prioridad para todos nosotros en la Alianza para la...

COVID-19 Update: A Message from LRA President & CEO

March 18, 2020 Dear Friends, Your well-being is the utmost priority for all of us at the Lupus Research Alliance (LRA)....